Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: Implications for predictive testing-Reference-Cited by-同舟云学术

Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: Implications for predictive testing

Published:2007-12-11 Issue:8 Volume:122 Page:1810-1819
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Almeida Gabriela M.,Duarte Tiago L.,Farmer Peter B.,Steward William P.,Jones George D.D.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference51 articles.

1. Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies;Reed;Cancer Res,1993

2. The measurement of cisplatin-DNA adduct levels in testicular cancer patients;Reed;Carcinogenesis,1988

3. Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy;Reed;Proc Natl Acad Sci USA,1987

4. Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation;Fichtinger-Schepman;Cancer Res,1990

5. Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry;Parker;Carcinogenesis,1991

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into bulky DNA damage formation and nucleotide excision repair from high-resolution genomics;DNA Repair;2023-10

2. Re-Analysis of Non-Small Cell Lung Cancer and Drug Resistance Microarray Datasets with Machine Learning;Cybernetics and Systems;2023-02-02

3. Effects of Sorafenib and Quercetin Alone or in Combination in Treating Hepatocellular Carcinoma: In Vitro and In Vivo Approaches;Molecules;2022-11-21

4. Caerin 1 Peptides, the Potential Jack-of-All-Trades for the Multiple Antibiotic-Resistant Bacterial Infection Treatment and Cancer Immunotherapy;BioMed Research International;2022-04-11

5. DNA Repair Capacity for Personalizing Risk and Treatment Response − Assay Development and Optimization in Human Peripheral Blood Mononuclear Cells (PBMCs);DNA Repair;2022-03